Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

ARA67/PAT1 functions as a repressor to suppress androgen receptor transactivation.

Zhang Y, Yang Y, Yeh S, Chang C.

Mol Cell Biol. 2004 Feb;24(3):1044-57. Erratum in: Mol Cell Biol. 2004 Jun;24(12):5635.

2.

Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth.

Hsu CL, Chen YL, Ting HJ, Lin WJ, Yang Z, Zhang Y, Wang L, Wu CT, Chang HC, Yeh S, Pimplikar SW, Chang C.

Mol Endocrinol. 2005 Feb;19(2):350-61.

PMID:
15514032
3.
4.

Identification and characterization of a novel androgen receptor coregulator ARA267-alpha in prostate cancer cells.

Wang X, Yeh S, Wu G, Hsu CL, Wang L, Chiang T, Yang Y, Guo Y, Chang C.

J Biol Chem. 2001 Nov 2;276(44):40417-23.

5.

Supervillin associates with androgen receptor and modulates its transcriptional activity.

Ting HJ, Yeh S, Nishimura K, Chang C.

Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):661-6.

6.

Modulation of androgen receptor transactivation by FoxH1. A newly identified androgen receptor corepressor.

Chen G, Nomura M, Morinaga H, Matsubara E, Okabe T, Goto K, Yanase T, Zheng H, Lu J, Nawata H.

J Biol Chem. 2005 Oct 28;280(43):36355-63.

8.

Transgelin functions as a suppressor via inhibition of ARA54-enhanced androgen receptor transactivation and prostate cancer cell growth.

Yang Z, Chang YJ, Miyamoto H, Ni J, Niu Y, Chen Z, Chen YL, Yao JL, di Sant'Agnese PA, Chang C.

Mol Endocrinol. 2007 Feb;21(2):343-58.

PMID:
17082327
9.

Identification and characterization of androgen receptor associated coregulators in prostate cancer cells.

Sampson ER, Yeh SY, Chang HC, Tsai MY, Wang X, Ting HJ, Chang C.

J Biol Regul Homeost Agents. 2001 Apr-Jun;15(2):123-9. Review.

PMID:
11501969
11.

Functional analysis of androgen receptor N-terminal and ligand binding domain interacting coregulators in prostate cancer.

Yeh S, Sampson ER, Lee DK, Kim E, Hsu CL, Chen YL, Chang HC, Altuwaijri S, Huang KE, Chang C.

J Formos Med Assoc. 2000 Dec;99(12):885-94. Review.

PMID:
11155740
12.

A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth.

Miyamoto H, Rahman M, Takatera H, Kang HY, Yeh S, Chang HC, Nishimura K, Fujimoto N, Chang C.

J Biol Chem. 2002 Feb 15;277(7):4609-17.

13.

Suppression of androgen receptor transactivation and prostate cancer cell growth by heterogeneous nuclear ribonucleoprotein A1 via interaction with androgen receptor coregulator ARA54.

Yang Z, Chang YJ, Miyamoto H, Yeh S, Yao JL, di Sant'Agnese PA, Tsai MY, Chang C.

Endocrinology. 2007 Mar;148(3):1340-9.

PMID:
17110431
14.
15.

CR6-interacting factor 1 represses the transactivation of androgen receptor by direct interaction.

Suh JH, Shong M, Choi HS, Lee K.

Mol Endocrinol. 2008 Jan;22(1):33-46.

PMID:
17885209
17.
18.

Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer.

Hu YC, Yeh S, Yeh SD, Sampson ER, Huang J, Li P, Hsu CL, Ting HJ, Lin HK, Wang L, Kim E, Ni J, Chang C.

J Biol Chem. 2004 Aug 6;279(32):33438-46.

19.

Mutations in the helix 3 region of the androgen receptor abrogate ARA70 promotion of 17beta-estradiol-induced androgen receptor transactivation.

Thin TH, Kim E, Yeh S, Sampson ER, Chen YT, Collins LL, Basavappa R, Chang C.

J Biol Chem. 2002 Sep 27;277(39):36499-508.

Supplemental Content

Support Center